Rate of Glucose Fall Does Not Affect Counterregulatory Hormone Responses to Hypoglycemia in Normal and Diabetic Humans

To test the hypothesis that variations in rate of glucose fall influence counterregulatory hormone responses to hypoglycemia, we have modified the glucose-clamp technique to provide a reproducible hypoglycemic stimulus in normal and type I diabetic subjects that varied only in the rate of glucose fall. Responsive elevations in plasma epinephrine and norepinephrine and in growth hormone, glucagon, and cortisol were not significantly affected by a ninefold change in the rate at which plasma glucose was lowered from 83 ± 1 to 50 ± 1 mg/dl in normal subjects. Similarly, wide variation in the rate of fall produced no substantive differences in counterregulatory hormone responses to hypoglycemia in diabetic subjects. The plasma glucose threshold at which epinephrine release began, determined from the slow-fall studies, was 63 ± 3 mg/dl in normal subjects but exhibited a wide range (48-74 mg/dl). Similar values were found in the diabetics. Thresholds for growth hormone, cortisol, and glucagon were slightly lower, ranging from 45 to 68 mg/dl in the normals. Our data suggest that counterregulatory hormone responses to hypoglycemia are triggered by the glucose level per se and not by its rate of fall. Furthermore, individual differences in glucose thresholds for epinephrine release may contribute to variations in the glucose level associated with hypoglycemic symptoms.

[1]  R. DeFronzo,et al.  A Test of the Hypothesis that the Rate of Fall in Glucose Concentration Triggers Counterregulatory Hormonal Responses in Man , 1977, Diabetes.

[2]  D. Diederich,et al.  Galvanic Skin Reflex and Plasma Free Fatty Acids During Insulin Reactions , 1964, Diabetes.

[3]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[4]  R. Sherwin,et al.  Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. , 1979, The Journal of clinical investigation.

[5]  A. Brickman,et al.  Resistance to symptomatic insulin reactions after fasting. , 1972, The Journal of clinical investigation.

[6]  F. Greenwood,et al.  Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.

[7]  J. Tobin,et al.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man. , 1976, Journal of applied physiology.

[8]  R. Unger,et al.  Pancreatic glucagon secretion in normal and diabetic subjects. , 1969, The American journal of the medical sciences.

[9]  P. Cryer,et al.  The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. , 1976, The Journal of clinical investigation.

[10]  S. Glick Hypoglycemic threshold for human growth hormone release. , 1970, The Journal of clinical endocrinology and metabolism.

[11]  M. Fabrykant,et al.  Dynamics of the hypoglycemic reaction. , 1948 .

[12]  R. Campbell,et al.  Counterregulatory Hormonal Responses to Rapid Glucose Lowering in Diabetic Man , 1979, Diabetes.

[13]  P. Cryer,et al.  Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. , 1980, The Journal of clinical endocrinology and metabolism.

[14]  R. DeFronzo,et al.  Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. , 1985, Annals of internal medicine.

[15]  P. D. de Moor,et al.  Fluorimetric determination of free plasma 11-hydroxycorticosteroids in man. , 1960, Acta endocrinologica.

[16]  P. Brunetti,et al.  Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion , 1983, Diabetes.

[17]  S. Berson,et al.  Separation of Antibody-Bound and Unbound Peptide Hormones Labelled with Iodine-131 by Talcum Powder and Precipitated Silica , 1966, Nature.

[18]  D. Johnson,et al.  Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man. , 1977, The Journal of clinical endocrinology and metabolism.

[19]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[20]  P. Cryer,et al.  Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. , 1985, The New England journal of medicine.

[21]  P. Cryer,et al.  Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. , 1984, The New England journal of medicine.

[22]  P. Cryer,et al.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. , 1980, The Journal of clinical investigation.